The Type 7b Secretion System of S. aureus and Its Role in Colonization and Systemic Infection.

Staphylococcus aureus bloodstream infections colonization polymorphic toxins type 7 secretion system

Journal

Infection and immunity
ISSN: 1098-5522
Titre abrégé: Infect Immun
Pays: United States
ID NLM: 0246127

Informations de publication

Date de publication:
16 05 2023
Historique:
medline: 18 5 2023
pubmed: 12 4 2023
entrez: 11 4 2023
Statut: ppublish

Résumé

Staphylococcus aureus bears a type 7b secretion system (T7bSS) that assembles in the bacterial envelope to promote the secretion of WXG-like proteins and toxic effectors bearing LXG domains. Cognate immunity proteins bind cytosolic effectors to mute their toxicity prior to secretion. T7b-secreted factors have been associated with the pathogenesis of staphylococcal disease and intraspecies competition. We identified earlier strain WU1, an S. aureus ST88 isolate that caused outbreaks of skin and soft tissue infections in mouse breeding facilities. WU1 was also found to persistently colonize the nasopharynx of animals, suggesting a strong host adaptation. In this manner, WU1 colonization and infectivity in mice resembles that of methicillin-sensitive and -resistant S. aureus strains in humans, where nasal carriage is a major risk factor for invasive infections. Here, animals were colonized with wild-type or T7-deficient WU1 strains or combinations thereof. Absence of the T7bSS did not affect colonization in the nasopharynx of animals, and although fluctuations were observed in weekly samplings, the wild-type strain did not replace the T7-deficient strain in cocolonization experiments. Bloodstream infection with a T7b-deficient strain resulted in enhanced survival and reduced bacterial loads and abscesses in soft tissues compared to infection with wild-type WU1. Together, experiments using a mouse-adapted strain suggest that the T7bSS of S. aureus is an important contributor to the pathogenesis of invasive disease.

Identifiants

pubmed: 37039657
doi: 10.1128/iai.00015-23
pmc: PMC10187124
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0001523

Subventions

Organisme : NIAID NIH HHS
ID : F32 AI140643
Pays : United States
Organisme : NIAID NIH HHS
ID : K99 AI171164
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI038897
Pays : United States

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Elife. 2017 Jul 11;6:
pubmed: 28696203
Nature. 1983 Oct 20-26;305(5936):709-12
pubmed: 6226876
Int J Infect Dis. 2017 Nov;64:9-14
pubmed: 28882667
Nucleic Acids Res. 2011 Jun;39(11):4532-52
pubmed: 21306995
J Bacteriol. 2011 Apr;193(7):1583-9
pubmed: 21278286
PLoS Genet. 2021 Jan 7;17(1):e1009204
pubmed: 33411815
J Clin Microbiol. 2003 Apr;41(4):1717-9
pubmed: 12682167
Trends Microbiol. 2011 May;19(5):225-32
pubmed: 21353779
Science. 2013 Nov 15;342(6160):863-6
pubmed: 24233725
Ann Intern Med. 2019 Dec 17;171(12):940-941
pubmed: 31525739
J Exp Med. 2009 Oct 26;206(11):2417-27
pubmed: 19808256
FASEB J. 2009 Oct;23(10):3393-404
pubmed: 19525403
J Biol Chem. 2022 Sep;298(9):102318
pubmed: 35921891
Arch Intern Med. 2009 Jan 26;169(2):172-8
pubmed: 19171814
Proc Natl Acad Sci U S A. 2018 Jun 26;115(26):6846-6851
pubmed: 29891696
J Bacteriol. 2016 Dec 13;199(1):
pubmed: 27795323
J Bacteriol. 2017 Oct 31;199(23):
pubmed: 28874412
Biol Direct. 2012 Jun 25;7:18
pubmed: 22731697
PLoS One. 2013 Sep 02;8(9):e71142
pubmed: 24023720
J Infect Dis. 2006 Jun 1;193(11):1495-503
pubmed: 16652276
Infect Immun. 2018 Sep 21;86(10):
pubmed: 30061376
Infect Genet Evol. 2009 Jan;9(1):32-47
pubmed: 19000784
Proc Natl Acad Sci U S A. 2005 Jan 25;102(4):1169-74
pubmed: 15657139
Front Microbiol. 2017 May 05;8:819
pubmed: 28529509
Mol Microbiol. 2013 Nov;90(4):734-43
pubmed: 24033479
Science. 2005 Aug 19;309(5738):1245-8
pubmed: 16109881
PLoS Genet. 2021 Jul 19;17(7):e1009682
pubmed: 34280190
Proc Natl Acad Sci U S A. 2020 Aug 25;117(34):20836-20847
pubmed: 32769205
J Infect Dis. 2005 Feb 1;191(3):444-52
pubmed: 15633104
J Bacteriol. 2018 Sep 24;200(20):
pubmed: 30082459
Lancet Infect Dis. 2012 Sep;12(9):703-16
pubmed: 22917102
Trends Microbiol. 2017 Nov;25(11):893-905
pubmed: 28641931
Nucleic Acids Res. 1989 May 11;17(9):3469-78
pubmed: 2657660
Pediatr Infect Dis J. 2012 Apr;31(4):360-3
pubmed: 22189535
Lancet Infect Dis. 2005 Dec;5(12):751-62
pubmed: 16310147
J Bacteriol. 2018 Apr 9;200(9):
pubmed: 29440258
Front Cell Infect Microbiol. 2017 May 02;7:152
pubmed: 28512627
J Clin Microbiol. 2003 Dec;41(12):5718-25
pubmed: 14662966
Infect Immun. 2014 Oct;82(10):4144-53
pubmed: 25047846
J Bacteriol. 2003 Jun;185(11):3307-16
pubmed: 12754228
Microb Genom. 2015 Oct 30;1(4):e000036
pubmed: 28348819
Sci Rep. 2016 Apr 26;6:25163
pubmed: 27112266
mBio. 2019 Nov 12;10(6):
pubmed: 31719177
Mol Microbiol. 2003 Sep;49(6):1577-93
pubmed: 12950922
Nat Microbiol. 2016 Oct 10;2:16183
pubmed: 27723728
J Clin Microbiol. 2005 Dec;43(12):5992-5
pubmed: 16333087
Annu Rev Microbiol. 2021 Oct 8;75:471-494
pubmed: 34343022
N Engl J Med. 2001 Jan 4;344(1):11-6
pubmed: 11136954
Lancet Infect Dis. 2008 Feb;8(2):101-13
pubmed: 17974481
BMC Infect Dis. 2021 Jun 21;21(1):589
pubmed: 34154550
BMC Genomics. 2016 Mar 11;17:222
pubmed: 26969225
Clin Microbiol Rev. 1997 Jul;10(3):505-20
pubmed: 9227864
Front Microbiol. 2021 Jun 11;12:692023
pubmed: 34177874
BMC Genomics. 2016 Feb 29;17:152
pubmed: 26924200
mSphere. 2020 Dec 16;5(6):
pubmed: 33328347
J Bacteriol. 2016 Dec 13;199(1):
pubmed: 27795322
Plasmid. 2006 Jan;55(1):58-63
pubmed: 16051359
J Innate Immun. 2010;2(6):576-86
pubmed: 20829609
Mol Microbiol. 2008 Aug;69(3):736-46
pubmed: 18554323

Auteurs

Maksym Bobrovskyy (M)

Department of Microbiology, University of Chicago, Chicago, Illinois, USA.

Xinhai Chen (X)

Howard Taylor Ricketts Laboratory, University of Chicago, Lemont, Illinois, USA.

Dominique Missiakas (D)

Department of Microbiology, University of Chicago, Chicago, Illinois, USA.
Howard Taylor Ricketts Laboratory, University of Chicago, Lemont, Illinois, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH